HighVista Strategies »

Amedisys shares owned by HighVista Strategies

Quarter-by-quarter ownership of Amedisys (AMED) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Amedisys

Tip: Access up to 7 years of quarterly data

All positions including Amedisys held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amedisys by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.7M 39k 93.40

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Activision Blizzard
Vmware Cl A Com
Albertsons Cos Common Stock (ACI)
Immunovant (IMVT)
Capri Holdings SHS (CPRI)
Horizon Therapeutics Pub L SHS
stock
Seagen
Axsome Therapeutics (AXSM)
Structure Therapeutics Sponsored Ads (GPCR)
Amedisys (AMED)
Ideaya Biosciences (IDYA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Microsoft Corporation (MSFT)

View all positions for HighVista Strategies

Top funds holding Amedisys

Vanguard Group
Pentwater Capital Management
Alpine Associates Management
Millennium Management
Westchester Capital Management
Mackenzie Financial
Park West Asset Management
Melqart Asset Management
Alliancebernstein
Dimensional Fund Advisors
Kempen Capital Management
Marshall Wace
Henderson Group
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management

View all funds holding Amedisys